Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


UN Security Council adopts resolution condemning Iran attacks on Gulf states
Oman works to contain fire at Salalah port after drones strike
Strike hits Beirut apartment block as Israel presses attacks
Six killed in Swiss bus blaze after person reportedly sets themselves on fire
Thailand's Phuket airport closes runway after Air India Express plane malfunction
